EP 3723743 A4 20210908 - THE PHARMACEUTICAL COMBINATION COMPRISING DAPOXETINE, PHOSPHODIESTERASE TYPE-5 INHIBITOR AND ANTI-EMETIC AGENT
Title (en)
THE PHARMACEUTICAL COMBINATION COMPRISING DAPOXETINE, PHOSPHODIESTERASE TYPE-5 INHIBITOR AND ANTI-EMETIC AGENT
Title (de)
PHARMAZEUTISCHE KOMBINATION MIT DAPOXETIN, PHOSPHODIESTERASE-TYP-5 -INHIBITOR UND ANTIEMETIKUM
Title (fr)
COMBINAISON PHARMACEUTIQUE COMPRENANT DE LA DAPOXÉTINE, UN INHIBITEUR DE PHOSPHODIESTÉRASE DE TYPE 5 ET UN AGENT ANTIÉMÉTIQUE
Publication
Application
Priority
- TR 201720443 A 20171215
- TR 2018050806 W 20181213
Abstract (en)
[origin: WO2019203753A2] The present invention relates to a pharmaceutical combination comprising dapoxetine, a PDE5 inhibitor and furthermore at least one anti-emetic agent.
IPC 8 full level
A61K 31/138 (2006.01); A61K 9/20 (2006.01); A61K 31/166 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01)
CPC (source: EP)
A61K 9/0056 (2013.01); A61K 9/2027 (2013.01); A61K 9/4858 (2013.01); A61K 31/138 (2013.01); A61K 31/166 (2013.01); A61K 31/454 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01)
Citation (search report)
- [Y] US 2002037828 A1 20020328 - WILSON LELAND F [US], et al
- [Y] US 2015202168 A1 20150723 - TURKYILMAZ ALI [TR], et al
- See references of WO 2019203753A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2019203753 A2 20191024; WO 2019203753 A3 20200116; EP 3723743 A2 20201021; EP 3723743 A4 20210908
DOCDB simple family (application)
TR 2018050806 W 20181213; EP 18915505 A 20181213